Members of Academia Europaea are invited to join the Zhejiang-Slovenia Glial Cell Joint Laboratory Workshop 2025 to take place in Zhejiang, China on October 10th, 2025.

The Laboratory:#

Zhejiang Chinese Medical University (ZCMU) - University of Lubljana (UL) Translational Gliology Laboratory was formed on March 14, 2024, by the memorandum of understanding signed by Prof. Zhong Chen, ZCMU President and Prof. Gregor Majdič, UL Rector. This memorandum named Prof. Vladimir Parpura MAE of ZCMU and Prof. Robert Zorec MAE of UL, members of Academia Europaea, as the codirectors of this joint laboratory. The laboratory subsequently received accreditation by and funding (for 3 years starting on January 1, 2025) from the Department of Science and Technology, Zhejiang Province People’s Government, as a Zhejiang international joint laboratory entitled “International Joint Laboratory Chinese Name: Zhejiang - Slovenia Glial Cell Biology Joint Laboratory; International Joint Laboratory English Name: ZCMU, China - UL, Slovenia Translational Gliology Laboratory”.

The Workshop:#

The Zhejiang-Slovenia Glial Cell Joint Laboratory Workshop 2025 is organized in Hangzhou, China, and is supported by Zhejiang Chinese Medical University, Zhejiang Province People’s Government and Evident.

Workshop program at glance:#

October 9, 2025

Arrival to Hangzhou: Pick up at the airport
Check in the hotel (Four Points by Sheraton Binjiang, 杭州滨江区东信大道868号)

19:00 Workshop Dinner

October 10, 2029#

8:15 Pick up at the hotel

WORKSHOP VENUE: Zhejiang Chinese Medical University (ZCMU), Binwen Campus, 23-101

8:30–9:00 Registration and Exhibition (Evident)

9:00–9:10 Welcoming remarks: “Introduction: Zhejiang - Slovenia Glial Cell Biology Joint Laboratory”, Vladimir PARPURA MAE, International Translational Neuroscience Research Institute (ITNRI), Zhejiang Chinese Medical University

9:10 – 10:00 Plenary lecture I: “Understanding lysosome fusion in astrocytes and its application in personalized treatment of prostate cancer using electrofused dendritic-tumor cell immunohybridomas”, Robert ZOREC MAE, University of Ljubljana, Ljubljana, Slovenia.

10:00–10:20 Exhibition and Refreshments (Evident)

10:20 – 11:50 SYMPOSIUM I (moderators: Robert ZOREC, University of Ljubljana and Vladimir PARPURA, Zhejiang Chinese Medical University)

10:20–10:50 “Two tales of astrocyte pathology: Alzheimer’s disease and amyotrophic lateral sclerosis” Vedrana MONTANA, International Translational Neuroscience Research Institute, Zhejiang Chinese Medical University, Hangzhou

10:50 – 11:20 “Amyloid precursor protein induces reactive astrogliosis”, Gretsen VELEZMORO JÁUREGUI, International Translational Neuroscience Research Institute, Zhejiang Chinese Medical University, Hangzhou

11:20–11:50 “Extracellular ATP and P2X7 receptor as main drivers of neuroinflammation in Alzheimer’s disease” Nikita ARNST, International Translational Neuroscience Research Institute, Zhejiang Chinese Medical University, Hangzhou

12:00–13:30 Lunch break

14:00 - 17:00 SYMPOSIUM II: (moderators: Robert ZOREC and Vladimir PARPURA)

14:00–14:40 “A survival pressure selection system for GPCR drug discovery” Xiangyu LIU, School of Pharmaceutical Sciences, Tsinghua University, Beijing

14:40–15:20 “Population calcium dynamics in cortical astrocytes during locomotion” Alexey SEMYANOV, College of Medicine, Jiaxing University, Jiaxing

15:20–15:40 Exhibition and Refreshments (Evident)

15:40–16:10 “Astrocytic control of fear consolidation and extinction” Yulan LI, Department of Physiology, School of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou

16:10–16:30 “Unlock the Dynamics of Life: Experience High-Speed, Super-Resolution Live-Cell Imaging with the MI-SIM.” Shutang ZENG, CSR Biotech, Guangzhou

16:30–17:00 General Discussion and Concluding Remarks (Robert ZOREC MAE)

19:00 Workshop Dinner

Workshop Secretariat:#

Ms. Na ZHI
Tel.+86 13656689000
E-mail: zhina@zcmu.edu.cn
WeChat ID: Imcarrotya
Ms. Emily Yan
Tel.+86 15355436693
E-mail: 20259019@zcmu.edu.cn
WeChat ID: emilyanxiaoyun


Download the programme.